|
|
 |
|
Viewing report
|
|
|
|
Genomics in Drug Discovery and Development
John Wiley and Sons Ltd, Nov 2008, Pages: 480
Early characterization of toxicity and efficacy would significantly impact the overall productivity of pharmaceutical R&D and reduce drug candidate attrition and failure. By describing the available platforms and weighing their relative advantages and disadvantages, including microarray data analysis, Genomics in Drug Discovery and Development introduces readers to the biomarker, pharmacogenomic, and toxicogenomics toolbox. The authors provide a valuable resource for pharmaceutical discovery scientists, preclinical drug safety department personnel, regulatory personnel, discovery toxicologists, and safety scientists, drug development professionals, and pharmaceutical scientists.
Customers who bought this item also bought
Toxicogenomics: A Powerful Tool for Toxicity Assessment
Companion Biomarkers in Drug Development
Biomarkers - Technologies, Markets and Companies
Developments in Early-Stage Toxicity Prediction
Bayesian Analysis of Gene Expression Data
Microarray Markets
Beyond Expression Arrays: Emerging Applications for Genomic Microarray Technology
Analyzing Microarray Gene Expression Data
Gene Expression Reagents Markets
Toxicity Biomarkers: Promising Tools for Accelerated Drug Development
Hepatotoxicity: From Genomics to In Vitro and In Vivo Models
Biomarkers: The Future of Next-Generation Drug R&D
|
|
|
|
